IndraLab

Statements

USP9X deubiquitinates PBX1. 1 / 1

| 1

reach

"Mutations or imbalances in the ubiquitination/deubiquitination signaling pathway in prostate cancer led to abnormalities of the deubiquitinase USP9X, which was also responsible for deubiquitinating PBX1 [41]."

39289660

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP9X deubiquitinates PBX1. 1 / 1

INDRA sources:

Databases

Reading